daunorubicin has been researched along with Encephalopathy, Toxic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, JE; Esterberg, E; Juckett, MB; Kahl, BS; Kim, J; Kim, K; Lionberger, J; Longo, WL; Medlin, SC; Williams, EC | 1 |
| Hsia, SH; Jaing, TH; Lin, JJ; Lin, JL; Lin, YP; Yang, SH | 1 |
1 trial(s) available for daunorubicin and Encephalopathy, Toxic
| Article | Year |
|---|---|
Augmented and standard Berlin-Frankfurt-Munster chemotherapy for treatment of adult acute lymphoblastic leukemia.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Daunorubicin; Humans; Infections; Middle Aged; Neurotoxicity Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Retrospective Studies; Risk Assessment; Survival Analysis; Treatment Outcome; Vincristine; Young Adult | 2008 |
1 other study(ies) available for daunorubicin and Encephalopathy, Toxic
| Article | Year |
|---|---|
Hyperammonemic encephalopathy after induction chemotherapy for acute lymphoblastic leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Daunorubicin; Humans; Hyperammonemia; Infant; Male; Neurotoxicity Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Treatment Outcome; Vincristine | 2009 |